Residual disease after re-excision lumpectomy for close margins

Journal of Surgical Oncology

Volumn 99, Issue 2, 2009, Pages 99-103

  Sabel, Michael S ^a,b   Rogers, Kendra ^a   Griffith, Kent ^a   Jagsi, Reshma ^a   Kleer, Celina G ^a   Diehl, Kathleen A ^a   Breslin, Tara M ^a   Cimmino, Vincent M ^a   Chang, Alfred E ^a   Newman, Lisa A ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b 3304 Cancer Center ^*  (United States)

Author keywords

Breast cancer; Ductal carcinoma in situ; Lumpectomy; Margins

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER PATIENT; CANCER STAGING; FEMALE; HUMAN; INCIDENCE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; TUMOR VOLUME; BREAST TUMOR; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; SEGMENTAL MASTECTOMY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM, RESIDUAL;

EID: 59649104268     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21215     Document Type: Article

References (29)

1. Clarke M, Collins R, Darby S, et al.: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: An overview of the randomized trials. Lancet 2005;366:2087-2106.
2. Cabioglu N, Hunt KK, Sahin AA, et al.: Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 2007;14:1458-1471.
3. Smitt MC, Horst K: Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer. Ann Surg Oncol 2007;14:1040-1044.
4. Waljee JF, Hu ES, Newman LA, et al.: Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol 2008;15:1297-1303.
5. Cellini C, Hollenbeck ST, Christos PJ, et al.: Factors associated with residual breast cancer after re-excision for close or positive margins. Ann Surg Oncol 2004;11:915-920.
6. Keskek M, Kothari M, Ardehali B, et al.: Factors predisposing to cavity margin positiviey following conservation surgery for breast cancer. Eur J Surg Oncol 2004;30:1058-1064.
7. Jacobs L: Positive margins: The challenge continues for breast surgeons. Ann Surg Oncol 2008;15:1271-1272.
8. Ramanah R, Pivot X, Sautiere JL, et al.: Predictors of re-excision for positive or close margins in breast-conservation therapy for pT1 tumors. Am J Surg 2008;195:770-774.
9. Gwin JL, Eisenberg BL, Hoffman JP, et al.: Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg 1993;218:729-734.
10. Kearney TJ, Morrow M: Effect of re-excision on the success of breast-conserving surgery. Ann Surg Oncol 1995;2:303-307.
11. Papa MZ, Zippel D, Koller M, et al.: Positive margins of breast biopsy: Is re-excision always necessary? J Surg Oncol 1999;70:167-171.
12. Ratanawichitrasin A, Rybicki LA, Steiger E, et al.: Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ. J Am Coll Surg 1999;188:17-21.
13. Miller AR, Brandao G, Prihoda TJ, et al.: Positive margins following surgical resection of breast carcinoma: Analysis of pathologic correlates. J Surg Oncol 2004;86:134-140.
14. Taghian A, Mohiuddin M, Jagsi R, et al.: Current perceptions regarding surgical margin status after breast-conserving therapy: Results of a survey. Ann Surg 2005;241:629-639.
15. Dewar JA, Arriagada R, Benhamou S, et al.: Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (institut Gustave-Roussy 1970-1982). Cancer 1995;76:2260-2265.
16. Freedman G, Fowble B, Hanlon A, et al.: Patients with early-stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005-1015.
17. Park C, Mitsumori M, Recht A, et al.: The relationship between pathologic margin status and outcome after breast conserving therapy. Int J Radiat Oncol Biol Phys 1998;42:125.
18. Anscher MS, Jones P, Prosnitz LR, et al.: Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 1993;218:22-228.
19. Smitt MC, Nowels K, Carlson RW, et al.: Predictors of re-excision findings and recurrence after breast conservation. Int J Radiat Oncol Biol Phys 2003;57:979-985.
20. Santiago RJ, Wu L, Harris E, et al.: Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast carcinoma: The University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 2004;58:233-240.
21. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al.: Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 1998;40:851-858.
22. Pittinger TP, Maronian NC, Poulter CA, et al.: Importance of margins status in outcome of breast-conserving surgery for carcinoma. Surgery 1994;116:605-608.
23. Obedian E, Haffty BG: Negative margin status improves local control in conservatively managed breast cancer patients. Cancer J Sci Am 2000;6:28-33.
24. Pierce LJ, Griffith KA, Hayman JA, et al.: Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys 2005;61:1317-1327.
25. Ben-David MA, Sturtz DE, Griffith KA, et al.: Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: The University of Michigan experience. Breast J 2007;13:392-400.
26. Holland R, Veling SH, Mravunac M, et al.: Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985;56:979-990.
27. Bartelink H, Horiot JC, Poortmans PM, et al.: Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10 year results of the randomized boost versus no boost EORTC 2281-1088 trail. J Clin Oncol 2007;25:3259-3265.
28. Jones H, Antonini N, Colette L, et al.: The impact of boost dose and margins on the local recurrence rate in breast conserving therapy: Results from the EORTC boost-no boost trial (presentation). Amercian Society for Therapeutic Radiology and Oncology (ASTRO) 49th Annual Meeting. Los Angeles, CA, 2007.
29. Morrow M, Harris JR: Practice guideline for the breast conservation therapy in the management of invasive breast carcinoma. JACS 2007;205:362-376.